This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Nieto, A. Articles by Rollán, E. Search for Related Content PubMed PubMed Citation Articles by Nieto, A. Articles by Rollán, E. Social Bookmarking                            What's this?

Immunohistochemical Expression of p53, Fibroblast Growth Factor-b, and Transforming Growth Factor- in Feline Vaccine-associated Sarcomas

Departamento de Patología Animal II, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain

Fifty feline sarcomas associated with vaccine-site injection were evaluated to determine the immunohistochemical expression of p53 protein, basic fibroblast growth factor (FGF-b), and transforming growth factor- (TGF-). Forty-one tumors (82%) were fibrosarcomas (FS), eight (16%) were malignant fibrous histiocytomas (MFH), and one (2%) was a chondrosarcoma (CS). Overexpression of p53 protein was observed in the nuclei of tumor cells in 28 (56%) sarcomas; FGF-b expression was found in the cytoplasm of tumor cells in 40 (80%) feline sarcomas, but the staining was more intense in the spindle-shaped cells of FS than in polygonal or round cells of MFH. The single CS faintly expressed FGF-b. The majority of feline vaccine-associated sarcomas (43 of 50, 86%) expressed moderate or intense staining for TGF- in the cytoplasm of tumor cells. Heterogeneous immunolabeling for p53, FGF-b, and TGF- was present in neoplastic, multinucleated giant cells. Intense expression of FGF-b was statistically associated with younger cats (P < 0.01) and with tumors with nodular growth patterns (P = 0.02). In addition, sarcomas negative for p53 protein expressed FGF-b more frequently than did p53-positive tumors (P = 0.04). The frequency of FGF-b immunostaining was significantly higher in sarcomas with intense expression of TGF- (P = 0.05). Immunohistochemical detection of p53 protein, FGF-b, and TGF- suggests that these growth-regulating proteins may play different roles in the development of sarcomas associated with vaccine sites.

Key words: Feline vaccine-associated sarcoma; FGF-b; immunohistochemistry; protein p53; TGF-.

Request reprints from Dr. A. I. Nieto, Departamento de Patología Animal II, Facultad de Veterinaria, Universidad Complutense de Madrid, 28040 Madrid (Spain).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. C. Durham, C. A. Popovitch, and M. H. Goldschmidt Feline Chondrosarcoma: A Retrospective Study of 67 Cats (1987-2005) J. Am. Anim. Hosp. Assoc., May 1, 2008; 44(3): 124 - 130. [Abstract] [Full Text] [PDF]

				U. Cardellino, Y. Ciribilli, V. Andreotti, P. Modesto, P. Menichini, G. Fronza, C. Pellegrino, and A. Inga Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach Mutagenesis, November 1, 2007; 22(6): 417 - 423. [Abstract] [Full Text] [PDF]

				H.-W Chang, S.-Y Ho, H.-F Lo, Y.-C Tu, C.-R Jeng, C.-H Liu, F.-I Wang, and V. F. Pang Vaccine-associated Rhabdomyosarcoma with Spinal Epidural Invasion and Pulmonary Metastasis in a Cat Vet. Pathol., January 1, 2006; 43(1): 55 - 58. [Abstract] [Full Text] [PDF]